These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 17060081
1. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer. Berggren de Verdier PJ, Kumar R, Adolfsson J, Larsson P, Norming U, Onelöv E, Wijkström H, Steineck G, Hemminki K. Scand J Urol Nephrol; 2006; 40(5):363-9. PubMed ID: 17060081 [Abstract] [Full Text] [Related]
3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS. Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [Abstract] [Full Text] [Related]
4. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M. Biochem Biophys Res Commun; 2006 Jan 20; 339(3):790-6. PubMed ID: 16316628 [Abstract] [Full Text] [Related]
5. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. Chapman EJ, Harnden P, Chambers P, Johnston C, Knowles MA. Clin Cancer Res; 2005 Aug 15; 11(16):5740-7. PubMed ID: 16115911 [Abstract] [Full Text] [Related]
6. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia. Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M. Clin Cancer Res; 1999 Jul 15; 5(7):1855-61. PubMed ID: 10430092 [Abstract] [Full Text] [Related]
7. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival. Grafström E, Egyházi S, Ringborg U, Hansson J, Platz A. Clin Cancer Res; 2005 Apr 15; 11(8):2991-7. PubMed ID: 15837753 [Abstract] [Full Text] [Related]
8. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M. J Surg Res; 2007 Dec 15; 143(2):422-7. PubMed ID: 17612565 [Abstract] [Full Text] [Related]
9. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Tsutsumi M, Tsai YC, Gonzalgo ML, Nichols PW, Jones PA. Oncogene; 1998 Dec 10; 17(23):3021-7. PubMed ID: 9881704 [Abstract] [Full Text] [Related]
10. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers. Grüttgen A, Reichenzeller M, Jünger M, Schlien S, Affolter A, Bosch FX. J Pathol; 2001 Jul 10; 194(3):311-7. PubMed ID: 11439363 [Abstract] [Full Text] [Related]
11. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S. Cancer Epidemiol Biomarkers Prev; 2008 Feb 10; 17(2):414-20. PubMed ID: 18268126 [Abstract] [Full Text] [Related]
12. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. Lee M, Sup Han W, Kyoung Kim O, Hee Sung S, Sun Cho M, Lee SN, Koo H. Pathol Res Pract; 2006 Feb 10; 202(6):415-24. PubMed ID: 16675157 [Abstract] [Full Text] [Related]
13. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis]. Tang SH, Yang DH, Luo HS, Yu JP, Shu JC. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun 10; 25(6):517-21. PubMed ID: 15231134 [Abstract] [Full Text] [Related]
14. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Pacifico A, Goldberg LH, Peris K, Chimenti S, Leone G, Ananthaswamy HN. Br J Dermatol; 2008 Feb 10; 158(2):291-7. PubMed ID: 18070208 [Abstract] [Full Text] [Related]
15. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia. Kresty LA, Mallery SR, Knobloch TJ, Li J, Lloyd M, Casto BC, Weghorst CM. Cancer Epidemiol Biomarkers Prev; 2008 Nov 10; 17(11):3179-87. PubMed ID: 18990760 [Abstract] [Full Text] [Related]
16. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. Silva J, Silva JM, Domínguez G, García JM, Cantos B, Rodríguez R, Larrondo FJ, Provencio M, España P, Bonilla F. J Pathol; 2003 Mar 10; 199(3):289-97. PubMed ID: 12579530 [Abstract] [Full Text] [Related]
17. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cavé H. Genes Chromosomes Cancer; 2003 May 10; 37(1):44-57. PubMed ID: 12661005 [Abstract] [Full Text] [Related]
18. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours. Le Frère-Belda MA, Cappellen D, Daher A, Gil-Diez-de-Medina S, Besse F, Abbou CC, Thiery JP, Zafrani ES, Chopin DK, Radvanyi F. Br J Cancer; 2001 Nov 16; 85(10):1515-21. PubMed ID: 11720438 [Abstract] [Full Text] [Related]
19. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Weber RG, Hoischen A, Ehrler M, Zipper P, Kaulich K, Blaschke B, Becker AJ, Weber-Mangal S, Jauch A, Radlwimmer B, Schramm J, Wiestler OD, Lichter P, Reifenberger G. Oncogene; 2007 Feb 15; 26(7):1088-97. PubMed ID: 16909113 [Abstract] [Full Text] [Related]
20. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Raschke S, Balz V, Efferth T, Schulz WA, Florl AR. Genes Chromosomes Cancer; 2005 Jan 15; 42(1):58-67. PubMed ID: 15495191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]